NEFAZODONE - CAS 83366-66-9
Catalog number: 83366-66-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C25H32ClN5O2
Molecular Weight:
470.01
COA:
Inquire
Targets:
5-HT Receptor
Description:
Nefazodone is a selective serotonin 5-HT2 receptor antagonist. It is an antidepressant under the development of Bristol-Myers Squibb. Its sale was discontinued in some countries due to the rare incidence of hepatotoxicity.
Publictions citing BOC Sciences Products
  • >> More
Purity:
95%
Appearance:
Crystalline Solid
Synonyms:
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one;82752-99-6(HYDROCHLORIDE)
Solubility:
Soluble in DMSO
Storage:
-20℃ Freezer
MSDS:
Inquire
Application:
antidepressant
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
Melting Point:
186 - 188℃
InChIKey:
VRBKIVRKKCLPHA-UHFFFAOYSA-N
InChI:
InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3
Canonical SMILES:
CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl
Current Developer:
Bristol-Myers Squibb
1.Different pH-sensitivity patterns of 30 sodium channel inhibitors suggest chemically different pools along the access pathway.
Lazar A1, Lenkey N2, Pesti K3, Fodor L4, Mike A5. Front Pharmacol. 2015 Sep 25;6:210. doi: 10.3389/fphar.2015.00210. eCollection 2015.
The major drug binding site of sodium channels is inaccessible from the extracellular side, drug molecules can only access it either from the membrane phase, or from the intracellular aqueous phase. For this reason, ligand-membrane interactions are as important determinants of inhibitor properties, as ligand-protein interactions. One-way to probe this is to modify the pH of the extracellular fluid, which alters the ratio of charged vs. uncharged forms of some compounds, thereby changing their interaction with the membrane. In this electrophysiology study we used three different pH values: 6.0, 7.3, and 8.6 to test the significance of the protonation-deprotonation equilibrium in drug access and affinity. We investigated drugs of several different indications: carbamazepine, lamotrigine, phenytoin, lidocaine, bupivacaine, mexiletine, flecainide, ranolazine, riluzole, memantine, ritanserin, tolperisone, silperisone, ambroxol, haloperidol, chlorpromazine, clozapine, fluoxetine, sertraline, paroxetine, amitriptyline, imipramine, desipramine, maprotiline, nisoxetine, mianserin, mirtazapine, venlafaxine, nefazodone, and trazodone.
2.Trazodone in the elderly: risk of extrapyramidal acute events.
Sotto Mayor J1, Pacheco AP1, Esperança S1, Oliveira e Silva A1. BMJ Case Rep. 2015 Jul 14;2015. pii: bcr2015210726. doi: 10.1136/bcr-2015-210726.
Trazodone is a second-generation atypical antidepressant exercising selective inhibitory action on the transport of serotonin. It also has an antagonist effect, similar to nefazodone, on the 5HT1 and 5HT2 receptors, probably due to the therapeutic effects of such substances. It is very effective in the treatment of depression, in anxiety and insomnia. Its known side effects mainly occur with prolonged use of daily doses of 150-200 mg. The ability to enhance drowsiness may be associated with some risk in elderly patients. This clinical case illustrates an acute extrapyramidal event induced by a low dose of trazodone.
3.Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2.
Xu W1, Lim J1, Goh CY1, Suen JY1, Jiang Y1, Yau MK1, Wu KC1, Liu L1, Fairlie DP1. J Chem Inf Model. 2015 Oct 26;55(10):2079-84. doi: 10.1021/acs.jcim.5b00500. Epub 2015 Oct 12.
Virtual screening of a drug database identified Carvedilol, Loratadine, Nefazodone and Astemizole as PAR2 antagonists, after ligand docking and molecular dynamics simulations using a PAR2 homology model and a putative binding mode of a known PAR2 ligand. The drugs demonstrated competitive binding and antagonism of calcium mobilization and ERK1/2 phosphorylation in CHO-hPAR2 transfected cells, while inhibiting IL-6 secretion in PAR2 expressing MDA-MB-231 breast cancer cells. This research highlights opportunities for GPCR hit-finding from FDA-approved drugs.
4.Drug-induced liver injury associated with antidepressive psychopharmacotherapy: An explorative assessment based on quantitative signal detection using different MedDRA terms.
Gahr M1, Zeiss R1, Lang D2, Connemann BJ1, Hiemke C3, Schönfeldt-Lecuona C1. J Clin Pharmacol. 2015 Oct 16. doi: 10.1002/jcph.662. [Epub ahead of print]
Drug-induced liver injury is a major problem of pharmacotherapy and is also frequent with antidepressive psychopharmacotherapy. However, there are only few studies using a consistent methodologic approach to study hepatotoxicity of a larger group of antidepressants. We performed a quantitative signal detection analysis using data from the Uppsala Monitoring Centre from the WHO that records adverse drug reaction (ADR)-data from worldwide sources; we retrieved substance- and country-specific (Australia, France, Germany, Italy, Spain, UK, and USA) ADR-data and calculated reporting odds ratios as measures for disproportionality within a case/non-case approach. To allow for identification of agents that cause severe forms of hepatotoxic ADR we used two different terms of the MeDRA ("Drug related hepatic disorders - comprehensive search" [DRHD-CS] and "… - severe events only" [DRHD-SEO]). Distribution of signals was heterogeneous throughout the different datasets and consistent findings were present only for few substances: agomelatine and tianeptine as well as both positive control agents (amineptine, nefazodone) generated signals related to DRHD-CS and DRHD-SEO in all analysed datasets.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related 5-HT Receptor Products


CAS 137328-52-0 LY 215840

LY 215840
(CAS: 137328-52-0)

LY 215840 is a potent antagonist of both Serotonin 2A receptor and Serotonin 7 receptor. It can reduce stimulatory effect of serotonin on aldosterone secretion ...

CAS 158876-82-5 Rupatadine

Rupatadine
(CAS: 158876-82-5)

Rupatadine, with the potential to treat allergic rhinitis and urticaria, is a potent and long-lasting dual antagonist of PAF/H1. in vitro: Without affecting con...

CAS 916918-84-8 Ansofaxine hydrochloride

Ansofaxine hydrochloride
(CAS: 916918-84-8)

Ansofaxine hydrochloride is a triple reuptake inhibitor of serotonin (IC50= 723 nM), dopamine (IC50= 491 nM) and norepinephrine reuptake (IC50= 763 nM).

CAS 115956-12-2 Dolasetron

Dolasetron
(CAS: 115956-12-2)

Dolasetron, a pseudopelletierine derivative, is a 5-HT3 receptor antagonist that could be used to relieve the nausea and vomiting caused by chemotherapy.

CAS 158930-09-7 Frovatriptan Succinate

Frovatriptan Succinate
(CAS: 158930-09-7)

Thesuccinate salt form of Frovatriptan, a carbazole derivative, has been found to be a 5-HT receptor agonist that could be used as an antimigraine agent.

CAS 133454-47-4 Iloperidone

Iloperidone
(CAS: 133454-47-4)

Iloperidone displays high affinity (Ki < 10 nM) for norepinephrine alpha(1)-adrenoceptors, dopamine D(3) and serotonin 5-HT(2A) receptors.

CAS 133025-23-7 Way 100135

Way 100135
(CAS: 133025-23-7)

Way 100135 is a selective 5-HT1A receptor antagonist originated by Wyeth with IC50 value of 15 nM. IC 50 values for 5-HT1B, 1C, 2,α1, α2 and D2 receptors are ov...

Ziprasidone-d8
(CAS: 1126745-58-1)

A labelled form of Ziprasidone which is an antagonist of both 5-HT and dopamine receptor and it has been studied to show effective antipsychotic activity.

LY 125180
(CAS: 74515-39-2)

LY 125180 is a serotonin antagonist.It can effect on serotonin uptake and serotonin synthesis in rat brain in vitro and in vivo.

CAS 13655-52-2 Alprenolol

Alprenolol
(CAS: 13655-52-2)

Alprenolol is a non-selective Beta-Adrenergic receptor and 5-HT1A receptor antagonist for the treatment of angina pectoris.

CAS 87760-53-0 Tandospirone

Tandospirone
(CAS: 87760-53-0)

Tandospironeis a potent and selective 5-HT1A receptor partial agonist with Ki of 27 nM. It significantly reduces haloperidol-induced bradykinesia in a dose depe...

MK212 hydrochloride
(CAS: 61655-58-1)

MK212 hydrochloride is a selective 5-HT2C serotonin receptor agonist. It displays selectivity for 5-HT2C over 5-HT2A with IC50 values of 0.028 and 0.42 μM for h...

CAS 99614-02-5 Ondansetron

Ondansetron
(CAS: 99614-02-5)

Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic.

CAS 439239-90-4 Lasmiditan

Lasmiditan
(CAS: 439239-90-4)

Lasmiditan is a high-affinity, highly selective 5-HT1F receptor agonist(Ki=2.1 nM) for the treatment of acute migraine.

CAS 508233-74-7 Vortioxetine

Vortioxetine
(CAS: 508233-74-7)

Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM ...

CAS 222318-55-0 (4E)-SUN9221

(4E)-SUN9221
(CAS: 222318-55-0)

A potent dual antagonist of α1-adrenergic receptor and 5-HT2 receptor

CAS 132414-02-9 Alosetron Hydrochloride(1:X)

Alosetron Hydrochloride(1:X)
(CAS: 132414-02-9)

The hydrochloride salt form of Alosetron, a 5HT3-receptor antagonist, could be used against bowel syndrome.

GSK215083
(CAS: 607742-80-3)

GSK215083 is a PET radioligand for the 5-hydroxytrypamine-6 (5HT6) receptor. It is a quinoline based compounds that acts by antagonising the 5-HT6 receptor. It ...

CAS 72797-41-2 Tianeptine

Tianeptine
(CAS: 72797-41-2)

Tianeptine is a selective facilitator of 5-HT uptake in vitro and in vivo with psychostimulant, anti-ulcer and anti-emetic properties.

CAS 261901-57-9 SB-269970 hydrochloride

SB-269970 hydrochloride
(CAS: 261901-57-9)

SB269970 HCl is a hydrochloride salt form of SB-269970, which is a 5-HT7 receptor antagonist with pKi of 8.3, exhibits >50-fold selectivity against other recept...

Chemical Structure

CAS 83366-66-9 NEFAZODONE

Quick Inquiry

Verification code

Featured Items